|
MTCH2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.63860000515592E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.27169999974974E-07 |
| Normal-vs-Stage2 |
5.565100E-04 |
| Normal-vs-Stage3 |
3.621100E-04 |
| Normal-vs-Stage4 |
1.66779999810629E-08 |
| Stage1-vs-Stage2 |
8.273000E-01 |
| Stage1-vs-Stage3 |
6.350400E-01 |
| Stage1-vs-Stage4 |
3.683600E-03 |
| Stage2-vs-Stage3 |
8.701200E-01 |
| Stage2-vs-Stage4 |
1.854500E-02 |
| Stage3-vs-Stage4 |
6.821000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.84020004684515E-09 |
| Normal-vs-AfricanAmerican |
3.35129999995409E-06 |
| Normal-vs-Asian |
7.418500E-02 |
| Caucasian-vs-AfricanAmerican |
4.634600E-01 |
| Caucasian-vs-Asian |
5.725400E-01 |
| AfricanAmerican-vs-Asian |
7.691600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.26009996776122E-10 |
| Normal-vs-Female |
3.76340000000086E-05 |
| Male-vs-Female |
3.024000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.89221999999933E-05 |
| Normal-vs-Extreme_Weight |
3.6204999998013E-08 |
| Normal-vs-Obese |
1.56859999989045E-07 |
| Normal-vs-Extreme_Obese |
3.464500E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.941800E-01 |
| Normal_Weight-vs-Obese |
8.320400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.148000E-01 |
| Extreme_Weight-vs-Obese |
2.865600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.022100E-02 |
| Obese-vs-Extreme_Obese |
2.561800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.220300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.83130000053211E-08 |
| Normal-vs-Age(61-80Yrs) |
3.78379999554923E-08 |
| Normal-vs-Age(81-100Yrs) |
1.018380E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.990200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.230800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.415400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.569600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.698000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.978600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.66150435024315E-11 |
| Normal-VS-Type2 PRCC |
1.822660E-03 |
| Normal-VS-KIRP CIMP |
4.08650002725608E-09 |
| Normal-VS-Unclassified PRCC |
2.618000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.273680E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.404300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.243570E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.74899999999734E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
5.252200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.024600E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51346999999191E-05 |
| Normal-vs-N1 |
1.98124999999383E-05 |
| Normal-vs-N2 |
1.011780E-04 |
| N0-vs-N1 |
5.331400E-01 |
| N0-vs-N2 |
3.481800E-02 |
| N1-vs-N2 |
6.428500E-02 |
|
|
